Immunogenicity and safety of two-dose or three-dose regimens of inactivated COVID-19 vaccines in patients with pulmonary tuberculosis: a randomised clinical trialPengfei Jin, Jingxin Li, Zhuopei Li et al.|Expert Review of Vaccines|2024Cited by 0